Alembic Ltd.

Financial

	Alembic	Arvind Smartspaces	Marathon NextgenReal
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	1.8 %	n/a	n/a
R&D as a % of Total Sales	0.06 %	n/a	n/a
Financials
5 yr Average ROE	13.7 %	7.21 %	8.92 %
5yr average Equity Multiplier	1.05	3.11	2.76
5yr Average Asset Turnover Ratio	0.05	0.22	0.21
5yr Avg Net Profit Margin	303.17 %	10.19 %	14.1 %
Price to Book	1.27	5.1	2.77
P/E	9.55	27.59	17.63
5yr Avg Cash Conversion Cycle	79.64 Days	2690.98 Days	281.42 Days
Inventory Days	237.67 Days	1190.43 Days	573.67 Days
Days Receivable	50.07 Days	2.85 Days	35.67 Days
Days Payable	292.14 Days	823.19 Days	181.55 Days
5yr Average Interest Coverage Ratio	181.25	3.03	2.02
5yr Avg ROCE	4.08 %	13.88 %	10.41 %
5yr Avg Operating Profit Margin	20.81 %	25.55 %	29.69 %
5 yr average Debt to Equity	0.0	0.39	1.14
5yr CAGR Net Profit	-3.98 %	1.12 %	47.21 %
5yr Average Return on Assets	13.04 %	2.39 %	3.45 %
Shareholdings
Promoter Holding	70.88 %	50.27 %	73.63 %
Share Pledged by Promoters	0.0	0.0	91.46 %
Change in Promoter Holding (3 Yrs)	0.0	-3.55 %	-1.34 %
Change in Mutual Fund Holding (3 Yrs)	-4.63 %	1.01 %	2.42 %

Business

	Alembic	Arvind Smartspaces	Marathon NextgenReal
Product Wise Break-Up	Product Wise Break-Up Real Estate 87.07 Active Pharmaceutical Ingredient (API) 12.91 Real estate 0 Others 0.02	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Real Estate 100.0 Real Estate 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Real estate 0 Real Estate 100.0
Location Wise Break-Up	Location Wise Break-Up India 95.48 Rest of the World 2.4 Others 2.12	Location Wise Break-Up Rest of the World 0 India 100.0	Location Wise Break-Up Rest of the World 0 India 100.0
Operating Profit Break-Up	Operating Profit Break-Up Real Estate 93.17 API 6.83	-	-
Asset Break-Up	Asset Break-Up Others 100	-	-